AM06 Trademark Application Published for Opposition

ChangeBridge: Trademarks - Advertising & Business (Class 035)

Published March 25th, 2026

Detected March 26th, 2026

Summary

The USPTO has published the AM06 trademark application for opposition, with a publication date of March 25, 2026. The application covers a wide range of goods and services, including food and beverages, advertising, and pharmaceutical preparations.

View original document View source feed page

What changed

The United States Patent and Trademark Office (USPTO) has published the trademark application for 'AM06' for opposition. The publication date is March 25, 2026. The application seeks to register the mark for a broad array of goods and services, including various food and beverage items (cocoa, coffee, tea, biscuits, cereal bars, bread, ice cream, pastries, confectionery, frozen yogurt, smoothies, juices, and non-alcoholic beverages), advertising and marketing services, commercial administration and licensing, market research, import-export agency services, retail store services for pharmaceutical and medical supplies, and pharmaceutical preparations for treating various medical conditions such as kidney disease, cancer, respiratory disorders, pain, and gastro-intestinal diseases.

This publication initiates a period during which any party who believes they would be harmed by the registration of this mark can file an opposition. Businesses operating in the food, beverage, advertising, or pharmaceutical sectors should review the application details if they believe the AM06 mark may conflict with their own existing trademarks or business interests. Failure to file an opposition within the designated period may result in the trademark being registered, potentially impacting market confusion or brand protection for other entities.

What to do next

Review AM06 trademark application details for potential conflicts with existing intellectual property.
Consider filing an opposition if the AM06 mark may cause market confusion or infringe on existing rights.

Source document (simplified)

← USPTO Trademark Applications

AM06

Published for Opposition TM79422449 Kind: published Mar 25, 2026

Abstract

Cocoa; coffee; tea; biscuits; high-protein cereal bars; bread; ice cream; pastries; Confectionery, namely, frozen confectionery, almond confectionery, chocolate confectionery, iced confectionery, nut confectionery, peanut confectionery and confectionery made of sugar; Confectionery, namely, cake, fruit jelly candy; frozen yogurt; yogurt-covered fruit, Dessert mousses; flavored jelly crystals for making jelly confectionery; honey; Advertising services; online advertising on a computer network; commercial administration of the licensing of the goods and services of others; market research studies; commercial information; import-export agency services; sales promotion for others; marketing services; provision of an online marketplace for buyers and sellers of goods and services; Retail store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; Whey beverages; Non-alcoholic beverages containing fruit juices; Non-alcoholic beverages with tea flavor; Non-alcoholic malt beverages; Non-alcoholic carbonated beverages; Non-alcoholic beer-flavored beverages; Non-alcoholic water-based beverages; Non-alcoholic beverages flavored with coffee; Non-alcoholic drinks made from seaweed; Aloe vera beverages, non-alcoholic; Honey-based beverages, non-alcoholic; fruit beverages; fruit juice; Flavored protein-enriched water beverages; Non-alcoholic vegetable juice beverages; Green vegetable juice beverages; protein-enriched sports beverages; smoothies; plant-based beverages, namely, non-alcoholic fruit juice beverages; Preparations for making non-alcoholic fruit-flavored beverages; Preparations for making non-alcoholic carbonated beverages; Cultures of microorganisms for medical or veterinary use; Drugs for medical purposes, namely, pharmaceutical preparations for the treatment of kidney disease; Drugs for medical purposes, namely, pharmaceutical preparations for the treatment of cancer; Drugs for medical purposes, namely, pharmaceutical preparations for the prevention and treatment of respiratory system disorders; Drugs for medical purposes, namely, pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; Drugs for medical purposes, namely, pharmaceutical preparations for the prevention and treatment of pain, cancer and tumors; Drugs for medical purposes, namely, pharmaceutical preparations for the prevention and treatment of pulmonary hypertension and pulmonary arterial hypertension; Drugs for medical purposes, namely, pharmaceutical preparations for the prevention and treatment of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, bulimia nervosa, anorexia and hypothyroidism; Drugs for medical purposes, namely, pharmaceutical preparations for the treatment of gastro-intestinal diseases; Drugs for medical purposes, namely, pharmaceutical preparations for the treatment of physical and psychological addictions, namely, gambling addiction, eating disorders and addictions, nicotine addiction, Internet addiction, drug addiction; Drugs for medical purposes, namely, pharmaceutical anxiolytic medications; Drugs for medical purposes, namely, pharmaceutical preparations for the treatment of liver diseases and disorders; Drugs for medical purposes, namely, oral sprays containing cannabis for relieving depression; Drugs for medical purposes, namely, pharmaceutical preparations for the treatment of infectious diseases, namely respiratory infections, eye infections; Drugs for medical purposes, namely, pharmaceutical preparations for the treatment of blood disorders, inflammation, sepsis and alopecia; Drugs for medical purposes, namely, psychiatric pharmaceutical preparations for the prevention and treatment of mood disorders, anxiety disorders, cognitive disorders, and schizophrenia; Pharmaceutical preparations for the treatment of viral, metabolic, ...